Condition
Opioid Induced Respiratory Depression
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Completed1
Not Yet Recruiting1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07227389Not Yet Recruiting
Timing of Opioid Administration and Postoperative Respiratory Depression.
NCT05338632Phase 1RecruitingPrimary
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05730062Phase 1UnknownPrimary
Influence of Oxycodone on Individuals Taking an SSRI
NCT01860885CompletedPrimary
Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure
Showing all 4 trials